Roche will publish its Sales Results for the 3rd Quarter of 2022 prior to the opening of the Swiss Stock Exchange on Tuesday, 18 October 2022.   07:00 CEST / 06:00 BST / 01:00 AM EDT / 10:00 PM PDT (evening before)   Release will be e-mailed and posted on the Roche IR website > click here Presentation slides will be posted on the Roche IR website > click here   14:00 – 15:30 CEST / 13:00 – 14:30 BST 08:00 – 09:30 AM EDT / 05:00 - 06:30 AM PDT   The webinar will start with presentations by senior management, followed by a Q&A session.   Presenters: Severin Schwan, CEO Roche Group Bill Anderson, CEO Roche Pharmaceuticals Thomas Schinecker, CEO Roche Diagnostics  Alan Hippe, Chief Financial and IT Officer We would like to invite all interested parties to participate in the webinar and to pre-register for the event here.*   Should you be unable to register for the webinar due to your company IT policy, please send an email to investor.relations@roche.com. A replay of the webcast will be available via > ir.roche.com   *privacy notice   Best regards,
Bruno Eschli Head of Investor Relations

Roche Investor Relations
Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com	Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com
Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com	Dr. Gerard Tobin Phone: +41 61 68-72942 e-mail: gerard.tobin@roche.com
Investor Relations North America
Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com

 

get the latest news and updates to your inbox.